Oriented Crystallization on Organic Monolayers to Control Concomitant Polymorphism.
The nucleation events and crystal growth can be guided by molecular recognition at the interface uttered by intermolecular interactions. Short-acting antimicrobial sulfa drug sulfathiazole is known for its concomitant crystallization with five existing polymorphs due to conformational flexibility and hydrogen bond synthon variation. The issue of concomitant crystallization of a drug in its development stage needs to be addressed for patent litigation that includes legal actions to protect patents against infringement. Functional self-assembled monolayer (SAM) of organic thiol on gold surface has been employed as an efficient approach to control concomitant nucleation of such flexible drug and emphasized. The crystallization on SAM surface is mostly kinetically driven and often nucleates novel metastable forms. The unknown sixth form of the drug is nucleated on designed SAM surface supported by spectroscopy, thermal analysis and X-ray diffraction studies.